Completed OBSERVATIONAL NCT05924061

The Role of Pentraxin 3 and Cathepsin B Levels in Preeclamptic Pregnancy

The Role of Pentraxin 3 and Cathepsin B Levels in the Second Trimester in Predicting of Maternal and Fetal Results in Preeclamptic Pregnancy

Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital

Conditions Cathepsin B Level Pentraxin 3 Level Pre-Eclampsia

Interventions Cathepsin B and pentraxin 3 levels in preeclampsia with pregnant women

Updated 4 times since 2023 Last updated: Jun 19, 2023 Started: Jan 1, 2022 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cathepsin B Level and Pentraxin 3 Level and is currently completed. Sanliurfa Mehmet Akif Inan Education and Research Hospital leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2023 — Jul 2024 [monthly]

Completed

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Data source: Sanliurfa Mehmet Akif Inan Education and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bursa, Turkey (Türkiye)